GlassScriptPhysician profile
Stephanie M Hoff
NPI 1386838399
$988.81
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $111 · 2021: $69.88.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $179.75 | 2019-2020 | |
| Amgen INC. | $153.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $138.78 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.96 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $69.37 | 2019-2020 | |
| Pfizer INC. | $62.58 | 2019-2020 | |
| Novo Nordisk INC | $61.67 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $59.58 | 2019 | |
| Abbvie INC. | $58.66 | 2021 | |
| Merck Sharp & Dohme LLC | $31.64 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.66 | 2019 | |
| Lilly USA, LLC | $23.04 | 2019 | |
| Supernus Pharmaceuticals, INC. | $17.13 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.82 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.22 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Hoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.